Business BridgeBio Pharma Hits New 52-Week High as Analysts Boost Ratings Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) reached a new 52-week high of $78.47 during trading on Friday, October 30, 2023. The stock closed at... Editorial2 January, 2026